<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Infectious Diseases &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/infectiousdisease/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Mefloquine malaria prophylaxis appears safe during pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/</link>
		<pubDate>Mon, 14 May 2012 17:09:43 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Travel Medicine]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[Mefloquine]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31746</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></description>
		
			<media:content duration="1:47" medium="video">
		<media:title><![CDATA[Mefloquine malaria prophylaxis appears safe during pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514epid0011.jpg"/>
	<media:keywords><![CDATA[malaria,Mefloquine,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Text Messaging about Flu Vaccine Associated with Increased Flu Vaccinations in Low-Income Children and Teens</title>
		<link>http://www.thedoctorschannel.com/view/text-messaging-about-flu-vaccine-associated-with-increased-flu-vaccinations-in-low-income-children-and-teens/</link>
		<pubDate>Mon, 07 May 2012 16:02:45 +0000</pubDate> 
				<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[The JAMA Report]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[flu]]></category>
		<category><![CDATA[influenza]]></category>
		<category><![CDATA[pedatrics]]></category>
		<category><![CDATA[vaccinations]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30865</guid>
		<description><![CDATA[Influenza infection is a common reason children and teens are hospitalized in the United States each year. While the flu vaccine is safe and effective just over half of children, age six months to 17 years, were vaccinated during last year’s flu season. A new study examined whether sending parents text message reminders would increase -]]></description>
		
			<media:content duration="1:42" medium="video">
		<media:title><![CDATA[Text Messaging about Flu Vaccine Associated with Increased Flu Vaccinations in Low-Income Children and Teens]]></media:title>
	<media:description><![CDATA[Influenza infection is a common reason children and teens are hospitalized in the United States each year. While the flu vaccine is safe and effective just over half of children, age six months to 17 years, were vaccinated during last year’s flu season. A new study examined whether sending parents text message reminders would increase -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/text-messaging-about-flu-vaccine-associated-with-increased-flu-vaccinations-in-low-income-children-and-teens/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Picture-7.png"/>
	<media:keywords><![CDATA[children,flu,influenza,pedatrics,The JAMA Report,vaccinations,vaccine]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Uveitis incidence increases following herpes zoster</title>
		<link>http://www.thedoctorschannel.com/view/uveitis-incidence-increases-following-herpes-zoster/</link>
		<pubDate>Thu, 12 Apr 2012 22:44:45 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ophthalmology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[herpes zoster]]></category>
		<category><![CDATA[uveitis]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28025</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results of a Taiwanese epidemiological study reported in the April issue of the Archives of Ophthalmology. “We suggest that patient eye condition be evaluated following diagnosis with HZ -]]></description>
		
			<media:content duration="1:22" medium="video">
		<media:title><![CDATA[Uveitis incidence increases following herpes zoster]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results of a Taiwanese epidemiological study reported in the April issue of the Archives of Ophthalmology. “We suggest that patient eye condition be evaluated following diagnosis with HZ -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/uveitis-incidence-increases-following-herpes-zoster/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120412epid006.jpg"/>
	<media:keywords><![CDATA[herpes zoster,uveitis]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Fecal microbiota transplant effective for recurrent C difficile infection</title>
		<link>http://www.thedoctorschannel.com/view/fecal-microbiota-transplant-effective-for-recurrent-c-difficile-infection/</link>
		<pubDate>Tue, 10 Apr 2012 23:06:18 +0000</pubDate> 
				<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[c difficile]]></category>
		<category><![CDATA[Fecal transplant]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27891</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Instillation of donor fecal material in the colon of patients with recurrent Clostridium difficile infection leads to rapid resolution of the condition in more than 90% of cases, investigators report in the American Journal of Gastroenterology online March 29. “Evidence continues to mount showing that FMT (fecal microbiota transplant) is -]]></description>
		
			<media:content duration="1:39" medium="video">
		<media:title><![CDATA[Fecal microbiota transplant effective for recurrent C difficile infection]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Instillation of donor fecal material in the colon of patients with recurrent Clostridium difficile infection leads to rapid resolution of the condition in more than 90% of cases, investigators report in the American Journal of Gastroenterology online March 29. “Evidence continues to mount showing that FMT (fecal microbiota transplant) is -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/fecal-microbiota-transplant-effective-for-recurrent-c-difficile-infection/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120410drgd001.jpg"/>
	<media:keywords><![CDATA[c difficile,Fecal transplant]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Occult Staph aureus bacteremia “important” in adult ED patients</title>
		<link>http://www.thedoctorschannel.com/view/occult-staph-aureus-bacteremia-%e2%80%9cimportant%e2%80%9d-in-adult-ed-patients/</link>
		<pubDate>Fri, 06 Apr 2012 21:08:00 +0000</pubDate> 
				<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Occult bacteremia]]></category>
		<category><![CDATA[Staph aureus]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27761</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of physicians from the National Taiwan University Hospital in Taipei note in a paper online March 19 in Clinical Infectious Diseases. “It’s not an uncommon experience for an -]]></description>
		
			<media:content duration="1:30" medium="video">
		<media:title><![CDATA[Occult Staph aureus bacteremia “important” in adult ED patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of physicians from the National Taiwan University Hospital in Taipei note in a paper online March 19 in Clinical Infectious Diseases. “It’s not an uncommon experience for an -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/occult-staph-aureus-bacteremia-%e2%80%9cimportant%e2%80%9d-in-adult-ed-patients/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120406epid002.jpg"/>
	<media:keywords><![CDATA[Occult bacteremia,Staph aureus]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>The case for empiric antifungal therapy for invasive candidiasis in preemies</title>
		<link>http://www.thedoctorschannel.com/view/the-case-for-empiric-antifungal-therapy-for-invasive-candidiasis-in-preemies/</link>
		<pubDate>Tue, 03 Apr 2012 23:15:14 +0000</pubDate> 
				<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Neonatology]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27589</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Empiric therapy in extremely low birth weight (ELBW) infants with invasive Candida infections is associated with improved outcomes (less death and neurodevelopmental impairment), according to retrospective data from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. “In infants at high risk of invasive -]]></description>
		
			<media:content duration="1:30" medium="video">
		<media:title><![CDATA[The case for empiric antifungal therapy for invasive candidiasis in preemies]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Empiric therapy in extremely low birth weight (ELBW) infants with invasive Candida infections is associated with improved outcomes (less death and neurodevelopmental impairment), according to retrospective data from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. “In infants at high risk of invasive -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/the-case-for-empiric-antifungal-therapy-for-invasive-candidiasis-in-preemies/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120403clin003.jpg"/>
	<media:keywords><![CDATA[]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Tenofovir in pregnancy has little effect on growth of infants of HIV-infected mothers</title>
		<link>http://www.thedoctorschannel.com/view/tenofovir-in-pregnancy-has-little-effect-on-growth-of-infants-of-hiv-infected-mothers/</link>
		<pubDate>Wed, 28 Mar 2012 22:35:00 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[pregnancy]]></category>
		<category><![CDATA[tenofovir]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27472</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Use of tenofovir in HIV-infected women during pregnancy is not associated with small-for-gestational age (SGA) or low birth weight (LBW) in their offspring, researchers report in a February 29th online paper in AIDS. &#8220;Overall,&#8221; Dr. George K. Siberry told Reuters Health by email, &#8220;the findings of this study should reassure -]]></description>
		
			<media:content duration="1:48" medium="video">
		<media:title><![CDATA[Tenofovir in pregnancy has little effect on growth of infants of HIV-infected mothers]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Use of tenofovir in HIV-infected women during pregnancy is not associated with small-for-gestational age (SGA) or low birth weight (LBW) in their offspring, researchers report in a February 29th online paper in AIDS. &#8220;Overall,&#8221; Dr. George K. Siberry told Reuters Health by email, &#8220;the findings of this study should reassure -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/tenofovir-in-pregnancy-has-little-effect-on-growth-of-infants-of-hiv-infected-mothers/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120328drgd003.jpg"/>
	<media:keywords><![CDATA[HIV,pregnancy,tenofovir]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Pandemic H1N1 flu hit cancer patients severely</title>
		<link>http://www.thedoctorschannel.com/view/pandemic-h1n1-flu-hit-cancer-patients-severely/</link>
		<pubDate>Tue, 20 Mar 2012 16:51:40 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[flu]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[solid tumors]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27038</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – The 2009 influenza A(H1N1) pandemic caused severe illness and mortality in cancer patients with solid tumors, investigators report in Cancer online February 22. “Early initiation of antiviral therapy is crucial in this patient population to decrease morbidity and probably mortality,” advise Dr. Roy F. Chemaly, with the University of Texas -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[Pandemic H1N1 flu hit cancer patients severely]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – The 2009 influenza A(H1N1) pandemic caused severe illness and mortality in cancer patients with solid tumors, investigators report in Cancer online February 22. “Early initiation of antiviral therapy is crucial in this patient population to decrease morbidity and probably mortality,” advise Dr. Roy F. Chemaly, with the University of Texas -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/pandemic-h1n1-flu-hit-cancer-patients-severely/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120320clin001.jpg"/>
	<media:keywords><![CDATA[cancer,flu,H1N1,solid tumors]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Investigational drug speeds healing of genital herpes lesions</title>
		<link>http://www.thedoctorschannel.com/view/investigational-drug-speeds-healing-of-genital-herpes-lesions/</link>
		<pubDate>Wed, 07 Mar 2012 22:30:13 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ASP2151]]></category>
		<category><![CDATA[genital herpes]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26119</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Compared to placebo, ASP2151 significantly shortens the time to healing of recurrent genital herpes, investigators report in the Journal of Infectious Diseases online February 20. “Three-day or single-day courses of ASP2151 appear to be effective and safe options for treatment of episodes of recurrent genital herpes,” conclude Ramona L. Rorig, -]]></description>
		
			<media:content duration="01:36" medium="video">
		<media:title><![CDATA[Investigational drug speeds healing of genital herpes lesions]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Compared to placebo, ASP2151 significantly shortens the time to healing of recurrent genital herpes, investigators report in the Journal of Infectious Diseases online February 20. “Three-day or single-day courses of ASP2151 appear to be effective and safe options for treatment of episodes of recurrent genital herpes,” conclude Ramona L. Rorig, -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/investigational-drug-speeds-healing-of-genital-herpes-lesions/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120307drgd004.jpg"/>
	<media:keywords><![CDATA[ASP2151,genital herpes]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>To prevent nosocomial norovirus spread, focus on symptomatic cases</title>
		<link>http://www.thedoctorschannel.com/view/to-prevent-nosocomial-norovirus-spread-focus-on-symptomatic-cases/</link>
		<pubDate>Mon, 13 Feb 2012 15:08:04 +0000</pubDate> 
				<category><![CDATA[Business of Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Public Health & Prevention]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Norovirus]]></category>
		<category><![CDATA[nosocomial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=24793</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Patients and health care workers (HCWs) with symptomatic nosocomial norovirus (NoV) infection are much more apt to transmit the virus than asymptomatic shedders, new research suggests. In email to Reuters Health, Dr. Faizel H. Sukhrie from the National Institute for Public Health, Center for Infectious Disease and Control, Bilthoven, the -]]></description>
		
			<media:content duration="1:29" medium="video">
		<media:title><![CDATA[To prevent nosocomial norovirus spread, focus on symptomatic cases]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Patients and health care workers (HCWs) with symptomatic nosocomial norovirus (NoV) infection are much more apt to transmit the virus than asymptomatic shedders, new research suggests. In email to Reuters Health, Dr. Faizel H. Sukhrie from the National Institute for Public Health, Center for Infectious Disease and Control, Bilthoven, the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/to-prevent-nosocomial-norovirus-spread-focus-on-symptomatic-cases/collection/infectiousdisease" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Thumbnail_20120213epid001-1.jpg"/>
	<media:keywords><![CDATA[Norovirus,nosocomial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
